BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belcher DA, Lucas A, Cabrales P, Palmer AF. Polymerized human hemoglobin facilitated modulation of tumor oxygenation is dependent on tumor oxygenation status and oxygen affinity of the hemoglobin-based oxygen carrier. Sci Rep 2020;10:11372. [PMID: 32647211 DOI: 10.1038/s41598-020-68190-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Yang F, Wang Y, Du T, Hou X. Emerging nanotherapeutics for facilitating photodynamic therapy. Chemical Engineering Journal 2023;451:138621. [DOI: 10.1016/j.cej.2022.138621] [Reference Citation Analysis]
2 Gu X, Palmer AF. ZIF-8 Metal–Organic Framework Nanoparticles Loaded with Hemoglobin as a Potential Red Blood Cell Substitute. ACS Appl Nano Mater 2022;5:5670-9. [DOI: 10.1021/acsanm.2c00608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lou Y, Shi Q, Zhang Y, Qi Y, Zhang W, Wang H, Lu J, Han B, Zhong H. Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals. Front Cell Dev Biol 2022;10:840466. [DOI: 10.3389/fcell.2022.840466] [Reference Citation Analysis]
4 Yan W, Lang T, Zhu R, Zhu X, Li Y, Wu T, Yin Q, Li Y. Anti-hypoxia nanosized drug delivery systems improving cancer therapy. Nano Today 2022;42:101376. [DOI: 10.1016/j.nantod.2022.101376] [Reference Citation Analysis]
5 Jiang F, Yang C, Ding B, Liang S, Zhao Y, Cheng Z, Liu M, Xing B, Ma P, Lin J. Tumor microenvironment-responsive MnSiO3-Pt@BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2021.12.096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Caballero D, Abreu CM, Lima AC, Neves NN, Reis RL, Kundu SC. Precision biomaterials in cancer theranostics and modelling. Biomaterials 2022;280:121299. [PMID: 34871880 DOI: 10.1016/j.biomaterials.2021.121299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
7 Gui CP, Wei JH, Chen YH, Fu LM, Tang YM, Cao JZ, Chen W, Luo JH. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma. Brief Bioinform 2021:bbab173. [PMID: 34237133 DOI: 10.1093/bib/bbab173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
8 Taguchi K. Pharmaceutical Technology Innovation Strategy Based on the Function of Blood Transport Proteins as DDS Carriers for the Treatment of Intractable Disorders and Cancer. Biol Pharm Bull 2020;43:1815-22. [PMID: 33268699 DOI: 10.1248/bpb.b20-00668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]